|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/40 | |
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61J 1/05 | |||
| A61K 31/215 | |||
| A61K 31/366 | |||
| A61K 31/404 | |||
| A61K 31/435 | |||
| A61K 31/47 | |||
| A61K 31/505 | |||
| C07K 14/47 | |||
| A61K 39/00 | |||
| A61P 3/00 | |||
| A61P 3/06 | |||
| A61P 5/00 | |||
| A61P 7/00 | |||
| A61P 9/00 | |||
| A61P 9/10 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3395836 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18162658.1 |
| Europos patento paraiškos padavimo data | 2012-01-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 11305088 | 2011-01-28 | EP | |
| 11305089 | 2011-01-28 | EP | |
| 11305513 | 2011-04-29 | EP | |
| 11305514 | 2011-04-29 | EP | |
| 11306039 | 2011-08-12 | EP | |
| 11306040 | 2011-08-12 | EP | |
| 11306201 | 2011-09-22 | EP | |
| 11306202 | 2011-09-22 | EP | |
| 11306449 | 2011-11-08 | EP | |
| 11306450 | 2011-11-08 | EP |
| (72) |
Hanotin, Corinne, FR
Bessac, Laurence, FR
CHAUDHARI, Umesh, US
|
| (73) |
Sanofi Biotechnology,
54 rue La Boétie, 75008 Paris,
FR
|
| (54) | HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS |
| HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS |